Electromedical Technologies, Inc.
EMED
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -82.11% | -18.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -82.11% | -18.13% | |||
| Cost of Revenue | -81.52% | -11.66% | |||
| Gross Profit | -82.34% | -20.29% | |||
| SG&A Expenses | -0.34% | 19.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -16.08% | -6.13% | |||
| Total Operating Expenses | -13.46% | 9.98% | |||
| Operating Income | -51.31% | -62.56% | |||
| Income Before Tax | -413.41% | 127.65% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -413.41% | 127.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -413.41% | 127.65% | |||
| EBIT | -51.31% | -62.56% | |||
| EBITDA | -51.54% | -63.11% | |||
| EPS Basic | -375.00% | 122.22% | |||
| Normalized Basic EPS | -333.33% | 127.27% | |||
| EPS Diluted | -1,200.00% | 105.56% | |||
| Normalized Diluted EPS | -800.00% | 109.09% | |||
| Average Basic Shares Outstanding | 20.18% | 21.91% | |||
| Average Diluted Shares Outstanding | -64.96% | 318.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||